ADPedKD:全球儿童常染色体显性多囊肾病管理在线平台
ADPKD是最常见的单基因肾衰竭病因,儿童期管理缺乏循证指南和风险分层系统。ADPedKD项目建立全球多中心儿童ADPKD观察性队列,通过七个区域独立但统一组织的网络数据库,收集遗传、临床、影像、实验室及治疗干预的回顾与前瞻纵向数据,旨在为儿童ADPKD的诊断、随访和治疗提供证据。
要点
- 儿童ADPKD缺乏循证管理指南和风险分层系统,需建立大型国际队列。
- ADPedKD为全球多中心观察性研究,覆盖七个区域,统一组织网络数据库。
- 数据库收集遗传、临床、影像、实验室及治疗干预的纵向数据。
核心结论
- ADPedKD项目旨在详细刻画迄今报道的最大国际儿童ADPKD队列,为制定统一的诊断、随访和治疗建议提供证据,并作为开发预测早期和进展性疾病风险的临床和/或生化标志物的平台。
研究设计与样本
- 全球ADPedKD为国际多中心观察性研究,聚焦儿童期诊断的ADPKD。
- 项目基于互操作网络数据库,包含非洲、亚洲、澳大利亚、欧洲、北美、南美和英国七个区域独立但统一组织的章节。
- 数据库使用详细的基础数据问卷(包括遗传学)结合随访访视数据录入,提供临床、影像和实验室发现以及治疗干预的回顾性和前瞻性纵向数据。
临床怎么用
- 临床可借助ADPedKD平台的多中心数据,为儿童ADPKD的诊断、随访和治疗提供参考,并关注可干预疾病因素。
局限性
- 原文未报告队列样本量、随访时长及具体研究结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic cause of renal failure. For several decades, ADPKD was regarded as an adult-onset disease. In the past decade, it has become more widely appreciated that the disease course begins in childhood. However, evidence-based guidelines on how to manage and approach children diagnosed with or at risk of ADPKD are lacking. Also, scoring systems to stratify patients into risk categories have been established only for adults. Overall, there are insufficient data on the clinical course during childhood. We therefore initiated the global ADPedKD project to establish a large international pediatric ADPKD cohort for deep characterization. METHODS: Global ADPedKD is an international multicenter observational study focusing on childhood-diagnosed ADPKD. This collaborative project is based on interoperable Web-based databases, comprising 7 regional and independent but uniformly organized chapters, namely Africa, Asia, Australia, Europe, North America, South America, and the United Kingdom. In the database, a detailed basic data questionnaire, including genetics, is used in combination with data entry from follow-up visits, to provide both retrospective and prospective longitudinal data on clinical, radiologic, and laboratory findings, as well as therapeutic interventions. DISCUSSION: The global ADPedKD initiative aims to characterize in detail the most extensive international pediatric ADPKD cohort reported to date, providing evidence for the development of unified diagnostic, follow-up, and treatment recommendations regarding modifiable disease factors. Moreover, this registry will serve as a platform for the development of clinical and/or biochemical markers predicting the risk of early and progressive disease.
引用
- De Rechter S, Bockenhauer D, Guay-Woodford LM, et al. ADPedKD: A Global Online Platform on the Management of Children With ADPKD. Kidney Int Rep. 2019. PMID: 31517146. doi:10.1016/j.ekir.2019.05.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。